Bayer ( (DE:BAYN) ) has shared an update.
Bayer Aktiengesellschaft announced a managerial transaction involving Dr. Paul Achleitner, a member of their supervisory body, who purchased shares valued at approximately 49,992.33 EUR on March 6, 2025. This transaction, conducted on the Xetra trading platform, reflects internal confidence in the company’s market position and may influence stakeholder perceptions of Bayer’s financial health.
More about Bayer
Bayer Aktiengesellschaft is a global enterprise with core competencies in the life science fields of health care and agriculture. The company is known for its pharmaceutical products, consumer health products, and agricultural solutions, focusing on innovation and sustainability to address global challenges.
YTD Price Performance: 21.40%
Average Trading Volume: 754,296
Technical Sentiment Consensus Rating: Buy
Current Market Cap: €22.84B
Learn more about BAYN stock on TipRanks’ Stock Analysis page.
Trending Articles:
Questions or Comments about the article? Write to editor@tipranks.com